Keyword results: Research site

Subscribe to UCT Keyword Search Feed

SATVI receives accreditation as UCT research site

The South African Tuberculosis Vaccine Initiative (SATVI) is an accredited UCT Research Site which offers major benefits to the organisation, including improved governance environment, five-yearly cycle of strategic review, and the potential to leverage additional funding for students and post-doctoral fellows.  SATVI recently published the findings of the first efficacy trial of a new infant TB vaccine (MVA85A) in almost 50 years (Tameris/Hatherill, Lancet 2013).